Jade Biosciences (JBIO) Assets (2020 - 2026)

Jade Biosciences has reported Assets for 7 years, with the latest figure at $319.4 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 312.0% year-over-year to $319.4 million; the trailing twelve-month figure through Mar 2026 stood at $319.4 million (up 312.0% YoY), and the FY2025 full-year result was $349.8 million, up 380.48% from the prior year.
• Assets for Q1 2026 stood at $319.4 million, down from $349.8 million in the prior quarter.
• The five-year high for Assets was $349.8 million in Q4 2025, with the low at $72.8 million in Q4 2024.
• Historically, Assets has averaged $159.4 million across 5 years, with a median of $140.9 million in 2023.
• Annual changes were most pronounced in 2024 — Assets tumbled 42.87% — and 2025, when it soared 380.48%.
• Jade Biosciences' Assets stood at $135.3 million in 2022, then dropped by 5.83% to $127.4 million in 2023, then slumped by 42.87% to $72.8 million in 2024, then surged by 380.48% to $349.8 million in 2025, then fell by 8.68% to $319.4 million in 2026.
• The last three Assets figures came in at $319.4 million (Q1 2026), $349.8 million (Q4 2025), and $202.4 million (Q3 2025), per Business Quant data.